Om

Impact BioMedical Inc. is a biotechnology company focused on discovering, validating, and commercializing science-based products and technologies for human healthcare and wellness. Its current business spans specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and direct-to-consumer wellness offerings. The company works through licensing, co-development, joint ventures, and other partnerships to advance technologies aimed at drug discovery and the prevention, inhibition, and treatment of neurological, oncologic, immune-related, and inflammatory conditions. It also develops products for broader wellness applications, including over-the-counter and consumer health categories. Based in Houston, Texas, Impact BioMedical Inc. plays a role in turning intellectual property and research-driven concepts into marketable healthcare solutions for pharmaceutical, consumer goods, and other industry partners.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I IMPACT BIOMEDICAL MED ENDAVU: Køb Impact BioMedical ($IBO) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Impact BioMedical, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.